The Germ Freak's Guide to Outwitting Colds and Flu: Guerilla Tactics to Keep Yourself Healthy at Home, at Work, and in the World


Correction: SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b


The Dictionary of Virology, 4th Edition


Relationship between reactive hemophagocytic syndrome (RHS) and multiple organ system failure (MOSF)


Correction


Ethics and Epidemics


A Clinician's Dictionary of Pathogenic Microorganisms


Third Congress for the European Society for Emerging Infections


Emergence and Control of Viral Respiratory Diseases


SARS Coronaviruses and Highly Pathogenic Influenza Viruses: Safety and Occupational Health for Laboratory Workers


Correction, vol. 10, no. 9


New and Re-Emerging Infectious Diseases


title: Manual of Travel Medicine and Health

text: Manual of Travel Medicine and Health


Healthcare-related Infectious Diseases


Women and Infectious Disease—Chronic Disease Interactions


Infectious Diseases and Maternal Morbidity and Mortality


SARS, the First Pandemic of the 21st Century


International Conference on Emerging Infectious Diseases


Malaria and the HIV virus: is there any interaction?


Respiratory Herpes simplex virus at the intensive care unit: a prospective study


Microbe: Are We Ready for the Next Plague?


Behind the Mask: How the World Survived SARS, the First Epidemic of the 21st Century


Acute respiratory infections, influenza-like illness and JIA: impact on disease activity and response to the influenza vaccine


Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus


The 26th Annual Symposium of The Protein Society: Abstracts


50th Golden Jubilee Conference of Indian Society of Hematology & Transfusion Medicine ISHTM 2009, November 19–22, 2009, New Delhi, India


Section VIII: Submitted abstracts selected for poster presentations — Session II, Friday, October 22, 2004


Thalidomide modulates macrophage-mediated inflammatory innate immune response during Klebsiella pneumoniae B5055 infection in BALB/c mice


title: Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections

text: Respiratory RNA viruses are constantly evolving, thus requiring development of additional prophylactic and therapeutic strategies. Harnessing the innate immune system to non-specifically respond to viral infection has the advantage of being able to circumvent viral mutations that render the virus resistant to a particular therapeutic agent. Viruses are recognized by various cellular receptors, including Toll-like receptor (TLR) 3 which recognizes double-stranded (ds)RNA produced during the viral replication cycle. TLR3 agonists include synthetic dsRNA such as poly (IC), poly (ICLC) and poly (AU). These agents have been evaluated and found to be effective against a number of viral agents. One major limitation has been the toxicity associated with administration of these drugs. Significant time and effort have been spent to develop alternatives/modifications that will minimize these adverse effects. This review will focus on the TLR3 agonist, poly (IC)/(ICLC) with respect to its use in treatment/prevention of respiratory viral infections.


title: Genome sequences published outside of Standards in Genomic Sciences, October - November 2012

text: The purpose of this table is to provide the community with a citable record of publications of ongoing genome sequencing projects that have led to a publication in the scientific literature. While our goal is to make the list complete, there is no guarantee that we may have omitted one or more publications appearing in this time frame. Readers and authors who wish to have publications added to subsequent versions of this list are invited to provide the bibliographic data for such references to the SIGS editorial office.


title: Genome sequences published outside of Standards in Genomic Sciences, July - October 2012


Abstracts of the Papers Presented in the XIX National Conference of Indian Virological Society, “Recent Trends in Viral Disease Problems and Management”, on 18–20 March, 2010, at S.V. University, Tirupati, Andhra Pradesh


High incidence of respiratory viruses in critically ill adult patients with respiratory failure


Lethal influenza virus A H1N1 infection in two relatives with autosomal dominant GATA-2 deficiency


Abstracts of the Papers (Oral/Poster) Presented During the XXI National Conference of Indian Virological Society (IVS) on “Immunobiology and Management of Viral Diseases in 21st Century”, Held from 8–10 November, 2012, at Indian Veterinary Research Institute (IVRI) Mukteswar Campus, Mukteswar, Nainital 263138, Uttarakhand


P042: Severe influenza infections requiring intensive care during winter 2012/2013


Savage Nature and Ecologic Exchange


Viral encephalitis caused by respiratory viruses


title: Thank you to Virology Journal's peer reviewers in 2013

text: The editors of Virology Journal would like to thank all our reviewers who have contributed to the journal in Volume 10 (2013). The success of any scientific journal depends on an effective and strict peer review process and Virology Journal could not operate without your contribution. We are grateful to the large number of reviewers (1026 to be exact!), who have done a great job in not only lifting the quality of the journal’s scientific peer reviewing process, but also helped us to achieve our goal of a median time to first decision of just 35 days. Our record time from submission to online, open access, publication in 2013 was 22 days for a Research Article [1] and 28 days for a Review [2]. This is a great achievement by any standard. We look forward to your continuous support of Virology Journal either as an invited reviewer or a contributing author in the years to come.


2014 ACMT Annual Scientific Meeting—March 28–30, 2014 Phoenix, AZ, USA


Truth in the Details


Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia


Mouse Development From Oocyte to Stem Cells


The Ups and Downs of Emerging Infectious Diseases at Your Fingertips


Correction: Triple Immunoglobulin Gene Knockout Transchromosomic Cattle: Bovine Lambda Cluster Deletion and Its Effect on Fully Human Polyclonal Antibody Production


Quiet Moment around the Campfire


Informing U.S. Federal Public Health Preparation for Emerging Virus Pandemic Threats at Ports of Entry


Village Doctors’ Acceptability to a Syndromic Surveillance System in Rural China


Searching for MERS and Novel Flu with Limited Resources


The Evolution of the WHO/NREVSS Influenza Surveillance System: The Challenges and Opportunities that Accompany Electronic Laboratory Data


Federal Interagency Interactions During Outbreaks of H7N9 Influenza and MERS-CoV


title: Methods To Identify Aptamers against Cell Surface Biomarkers

text: Aptamers are nucleic acid-based ligands identified through a process of molecular evolution named SELEX (Systematic Evolution of Ligands by Exponential enrichment). During the last 10-15 years, numerous aptamers have been developed specifically against targets present on or associated with the surface of human cells or infectious pathogens such as viruses, bacteria, fungi or parasites. Several of the aptamers have been described as potent probes, rivalling antibodies, for use in flow cytometry or microscopy. Some have also been used as drugs by inhibiting or activating functions of their targets in a manner similar to neutralizing or agonistic antibodies. Additionally, it is straightforward to conjugate aptamers to other agents without losing their affinity and they have successfully been used in vitro and in vivo to deliver drugs, siRNA, nanoparticles or contrast agents to target cells. Hence, aptamers identified against cell surface biomarkers represent a promising class of ligands. This review presents the different strategies of SELEX that have been developed to identify aptamers for cell surface-associated proteins as well as some of the methods that are used to study their binding on living cells.


title: Echinacea—A Source of Potent Antivirals for Respiratory Virus Infections

text: Extracts of Echinacea species have been used traditionally in North America for the control of symptoms of colds, influenza, and other diseases, and some of them have become very popular as “herbal medicines”. Recent studies have revealed that preparations derived from certain species and plant parts, but not all of them, possess potent antiviral activities, at non-cytotoxic concentrations, particularly against membrane-containing viruses. Thus all strains of human and avian influenza viruses tested (including a Tamiflu-resistant strain), as well as herpes simplex virus, respiratory syncytial virus, and rhinoviruses, were very sensitive to a standardized Echinacea purpurea preparation. In mechanistic studies the influenza virus-specific hemagglutinin and neuraminidase were inhibited. In addition some extracts displayed anti-inflammatory activity in virus-infected cells, and numerous other effects on the expression of cellular genes. Multiple components, either discrete compounds or mixtures, appeared to be responsible for the various antiviral activities.


Lower airway sampling greatly increases detection of respiratory viruses in critically ill patients: the COURSE study


Design and implementation of needs-specific critical care response teams


Computerised tomography (CT) in severe acute respiratory syndrome (SARS): late-stage acute respiratory disease syndrome (ARDS) and follow-up findings


Critically ill patients with severe acute respiratory syndrome (SARS) in a designated national SARS ICU: clinical features and predictors for mortality


Retrospective analysis of critically ill patients with severe acute respiratory syndrome admitted to an intensive care unit


Increase in methicillin-resistant Staphylococcus aureus acquisition and change in pathogen pattern associated with outbreaks of severe acute respiratory syndrome (SARS)


Abstracts of the XX World Allergy Congress™ 2007 December 2-6, 2007, Bangkok, Thailand


Correction: Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics


Correction: Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset


MERS-CoV


Year in review in Intensive Care Medicine 2014: I. Cardiac dysfunction and cardiac arrest, ultrasound, neurocritical care, ICU-acquired weakness, nutrition, acute kidney injury, and miscellaneous


Year in review in Intensive Care Medicine 2014: II. ARDS, airway management, ventilation, adjuvants in sepsis, hepatic failure, symptoms assessment and management, palliative care and support for families, prognostication, organ donation, outcome, organisation and research methodology


A survey of UK acute clinicians' knowledge of personal protective requirements for infectious diseases and chemical, biological, and radiological warfare agents


Prevalence of viral respiratory tract infections in acutely admitted and ventilated ICU patients: a prospective multicenter observational study


Middle East respiratory syndrome coronavirus (MERS-Cov) screening of exposed healthcare workers in a tertiary care hospital in Saudi Arabia


Infection prevention and control strategies for the Middle East respiratory syndrome coronavirus and outcome in Oman


Evaluation of REDCap as a Tool for Outbreak Data Management, Illinois, 2013-2014


2014 International Society for Disease Surveillance Conference Translating Research and Surveillance into Action


Response of the National Biosurveillance Integration Center to the Emergence of Porcine Epidemic Diarrhea Virus in the United States


Use of Syndromic Data for Enhanced Surveillance: MERS Like-Syndrome


Overcoming Operational Differences to Attain a National Picture for Novel Threats


Ebola, Enterovirus, MERS, Novel Flu, and other Challenges for Public Health Surveillance Practitioners


title: 8(th) International conference on management and rehabilitation of chronic respiratory failure: the long summaries – Part 3

text: This paper summarizes the Part 3 of the proceedings of the 8(th) International Conference on Management and Rehabilitation of Chronic Respiratory Failure, held in Pescara, Italy, on 7 and 8 May, 2015. It summarizes the contributions from numerous experts in the field of chronic respiratory disease and chronic respiratory failure. The outline follows the temporal sequence of presentations. This paper (Part 3) presents a section regarding Moving Across the Spectrum of Care for Long-Term Ventilation (Moving Across the Spectrum of Care for Long-Term Ventilation, New Indications for Non-Invasive Ventilation, Elective Ventilation in Respiratory Failure - Can you Prevent ICU Care in Patients with COPD?, Weaning in Long-Term Acute Care Hospitals in the United States, The Difficult-to-Wean Patient: Comprehensive management, Telemonitoring in Ventilator-Dependent Patients, Ethics and Palliative Care in Critically-Ill Respiratory Patients, and Ethics and Palliative Care in Ventilator-Dependent Patients).


Clinical characteristics and short-term outcomes of hiv patients admitted to an african intensive care unit


One Health: People, Animals, and the Environment


2014 ACVIM Forum Research Report Program


Oral Research Communications of the 23rd ECVIM‐CA Congress


Research Communications of the 24th ECVIM‐CA Congress


title: The 2014–2015 Ebola outbreak in West Africa: Hands On

text: The International Consortium for Prevention and Infection Control (ICPIC) organises a biannual conference (ICPIC) on various subjects related to infection prevention, treatment and control. During ICPIC 2015, held in Geneva in June 2015, a full one-day session focused on the 2014–2015 Ebola virus disease (EVD) outbreak in West Africa. This article is a non-exhaustive compilation of these discussions. It concentrates on lessons learned and imagining a way forward for the communities most affected by the epidemic. The reader can access video recordings of all lectures delivered during this one-day session, as referenced. Topics include the timeline of the international response, linkages between the dynamics of the epidemic and infection prevention and control, the importance of community engagement, and updates on virology, diagnosis, treatment and vaccination issues. The paper also includes discussions from public health, infectious diseases, critical care and infection control experts who cared for patients with EVD in Africa, in Europe, and in the United Sates and were involved in Ebola preparedness in both high- and low-resource settings and countries. This review concludes that too little is known about the pathogenesis and treatment of EVD, therefore basic and applied research in this area are urgently required. Furthermore, it is clear that epidemic preparedness needs to improve globally, in particular through the strengthening of health systems at local and national levels. There is a strong need for culturally sensitive approaches to public health which could be designed and delivered by social scientists and medical professionals working together. As of December 2015, this epidemic killed more than 11,000 people and infected more than 28,000; it has also generated more than 17,000 survivors and orphans, many of whom face somatic and psychological complications. The continued treatment and rehabilitation of these people is a public health priority, which also requires an integration of specific medical and social science approaches, not always available in West Africa.


Perspective and Surprise in the Floating World


Back Cover


Front Cover


2015 ACVIM Forum Research Abstract Program


Proceedings 26th Symposium ESVN‐ECVN


2014 ACVIM Forum Research Abstracts Program